Table 2.
The details of the Primers used for gene expression studies in the study.
Primer ID | Primer | Primer sequence (5′ to 3′) | Primer length (bp) | Product size (bp) | NCBI accession number |
---|---|---|---|---|---|
SLC9C1 | Forward | GGAACGCCTCGAATAAGCCT | 20 | 149 | XM_024994321.1 |
Reverse | TCAGCTCAAAGTTGCTCCCT | 20 | |||
HSP90AB1 | Forward | GTGACGATCTCCAACAGGCT | 20 | 213 | NM_001079637.1 |
Reverse | GTCGTTTTTGTCCGCCTCTG | 20 | |||
EFHD1 | Forward | AACGTGCCTCTACTTGGCAG | 20 | 145 | NM_001075832.1 |
Reverse | TTAACATCACTGGCCTCCCG | 20 | |||
ENO1 | Forward | ATGTCACCGAGCAGTGTGAG | 20 | 212 | NM_174049.2 |
Reverse | GATACTTGGTGGGAGCGAGG | 20 | |||
NFAT5 | Forward | ACCTCTTCCAGCCCTACCAT | 20 | 170 | XM_002694839.6 |
Reverse | AAGACTGTGTGCCTCTTCGG | 20 | |||
MT-ND2 | Forward | TCTCAGGCCAATGAACCGTA | 20 | 127 | NC_006853.1:4266–5307 |
Reverse | ATGCCCTGTGTTACTTCTGGG | 21 | |||
MT-CO1 | Forward | GTAACCGCACACGCATTTGT | 20 | 217 | NC_006853.1:5687–7231 |
Reverse | GGTACACGGTTCAGCCTGTT | 20 | |||
ADAM1B | Forward | GAGTGGGAATGACAGGCTCA | 20 | 119 | NW_020192236 |
Reverse | TGACAGAATCCCTCCTCCTAGT | 22 | |||
PRM1 | Forward | AAGATGTCGCAGACGAAGGAG | 21 | 222 | NM_174156.2 |
Reverse | GTGGCATTGTTCGTTAGCAGG | 21 | |||
RPL23 | Forward | CAGCGGTGGTAATTCGACAAC | 21 | 116 | NM_001035014.2 |
Reverse | GGCGGAACCTTTCATCTCG | 19 | |||
GAPDH | Forward | CTGAGGACCAGGTTGTCTCCTG | 22 | 141 | NM_001034034.1 |
Reverse | CCCTGTTGCTGTAGCCAAATTC | 22 | |||
CDH1 | Forward | CTGCATTCCTGGCTTTGGTG | 20 | 171 | NM_001002763.1 |
Reverse | GTAAGCACGCCATCTGTGTG | 20 | |||
CKIT | Forward | GAATAGCTGGCATCAGGGTG | 20 | 224 | AF263827.1 |
Reverse | CCAGATCCACATTCTCTCCATC | 22 | |||
PTPRC | Forward | TGGACGAAATTGCATCCCTCAGGA | 24 | 237 | NM_174156.2 |
Reverse | RTGGTCAGGACGTTTACAGCTCACA | 24 |